Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunoprecise Antibodies Ltd

0.6724
-0.0296-4.22%
Post-market: 0.69000.0176+2.62%19:52 EDT
Volume:630.98K
Turnover:433.11K
Market Cap:30.77M
PE:-0.60
High:0.7289
Open:0.7286
Low:0.6600
Close:0.7020
Loading ...

ImmunoPrecise Antibodies CFO Resignation and Succession

TIPRANKS
·
01 Jan

BRIEF-IPA Announces Resignation Of Chief Financial Officer

Reuters
·
01 Jan

Immunoprecise Antibodies Ltd - Kristin Taylor Resigns as CFO of Immunoprecise Antibodies

THOMSON REUTERS
·
01 Jan

Ipa Announces Resignation of Chief Financial Officer

THOMSON REUTERS
·
01 Jan

Immunoprecise Antibodies Ltd - Initiates CFO Succession Process

THOMSON REUTERS
·
01 Jan

IPA Announces Resignation of Chief Financial Officer

Business Wire
·
01 Jan

$116 Million Multifamily Asset Sale in Central California Coast Region Brokered by Marcus & Millichap’s Institutional Property Advisors

Business Wire
·
31 Dec 2024

ImmunoPrecise Antibodies Shows Market Confidence

TIPRANKS
·
23 Dec 2024

ImmunoPrecise Antibodies exhibits market confidence with insider transactions

TIPRANKS
·
23 Dec 2024

ImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with Insider Share Purchases

Business Wire
·
23 Dec 2024

ImmunoPrecise Antibodies to Showcase at Microcap Conference

TIPRANKS
·
19 Dec 2024

IPA to Present at The Microcap Conference 2025

Business Wire
·
19 Dec 2024

Marcus & Millichap’s Institutional Property Advisors Brokers $203 Million Sale and Arranges $127.8 Million Financing for Silicon Valley Multifamily Asset

Business Wire
·
19 Dec 2024

QIAGEN Stock Gains Following the Latest Launch of IPA Interpret

Zacks
·
13 Dec 2024

QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data

Business Wire
·
13 Dec 2024

ImmunoPrecise Antibodies price target lowered to $7 from $9 at H.C. Wainwright

TIPRANKS
·
11 Dec 2024

Immunoprecise Antibodies Ltd. : H.c. Wainwright Cuts Target Price to $7 From $9

THOMSON REUTERS
·
11 Dec 2024

ImmunoPrecise Antibodies Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
11 Dec 2024

Immunoprecise Antibodies Ltd reports results for the quarter ended October 31 - Earnings Summary

Reuters
·
10 Dec 2024

ImmunoPrecise Antibodies Q2 2025 GAAP EPS C$(0.09) Beats C$(0.10) Estimate, Sales C$6.13M Miss C$6.44M Estimate

Benzinga
·
10 Dec 2024